Freenome, Inc. (FRNM)
15.70
-0.76
(-4.59%)
USD |
NASDAQ |
Sep 23, 16:00
16.01
+0.31
(+1.97%)
Pre-Market: 09:07
Freenome Shareholders Equity (Quarterly) : 78.75M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 78.75M |
| March 31, 2026 | 87.02M |
| December 31, 2025 | 87.08M |
| September 30, 2025 | 87.82M |
| June 30, 2025 | 87.67M |
| Date | Value |
|---|---|
| March 31, 2025 | 86.92M |
| December 31, 2024 | 86.24M |
| September 30, 2024 | 85.40M |
| June 30, 2024 | 84.42M |
| March 31, 2024 | 0.0096M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Natera, Inc. | 1.821B |
| Intellia Therapeutics, Inc. | 727.71M |
| Twist Bioscience Corp. | 445.74M |
| Ionis Pharmaceuticals, Inc. | 439.74M |
| Veracyte, Inc. | 1.388B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 85.83M |
| Total Liabilities (Quarterly) | 7.078M |
| Current Ratio | 0.2046 |